The ImClone imPlosion has made a risky sector look even riskier. But that's not all that ails biotech.

The Fed is done "easing," but the deflationary shortfall of dollars remains unaddressed.

Paul Krugman and other pundits got splashed with Enron's mud last week. Should anyone care?

The markets are still out of whack, but the worst excesses of misvaluation have been repaired.

A marginal shift against expectations for sustained yen deflation is creating opportunities to short the Japanese government bond.

Don't forget that there's a currency play here too -- but you have to go to a little extra trouble to make it.

Gold's recent move to $300 represents one of the more promising signs that dollar deflation is finally at an end.

President Bush's Japan visit appears to have provided important impetus for a reflationary push.

The impact of pension problems on earnings and balance sheets is bad enough without imagining it's another Enron.

The New York Post stories about Cisco are a template for attacking every technology company in America.